Osteonecrosis of the jaw in multiple myeloma patients (the IFM registry)

被引：0
|
作者：
Fuzibet, Jean Gabriel [1 ]
Viellard, Marie Helene [2 ]
Rossignol, Benoit B. R. [1 ]
Doyen, Chantal C. D. [3 ]
Hulin, Cyril [4 ]
Garderet, Laurent L. G. [5 ]
Blanc, Michel M. B. [6 ]
Marit, Gerald [7 ]
Facon, Thierry T. F. [8 ]
Moreau, Philippe [9 ]
机构：
[1] CHU Archet, Dept Internal Med, Nice, France
[2] CHRU Roger Salengro, Dept Rheumatol, Lille, France
[3] CU Mont Godinne, Dept Hematol, Yvoir, Belgium
[4] CHU Brabois, Dept Internal Med, Nancy, France
[5] CHU St Antoine, Dept Hematol, Paris, France
[6] Ctr Hosp, Dept Hematol, Chambery, France
[7] CHRU Haut Leveque, Dept Hematol, Pessac, France
[8] CHRU Claude Huriez, Lille, France
[9] CHRU, Hotel Dieu, Dept Hematol, Nantes, France
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4809
引用
收藏
页码：276B / 276B
页数：1
相关论文
共 50 条
  • [31] Incidence of osteonecrosis of the jaw in patients with multiple myeloma and breast or prostate cancer on intravenous bisphosphonate therapy
    Wang, Estee P.
    Kaban, Leonard B.
    Strewler, Gordonj
    Raje, Noopur
    Troulis, Maria J.
    JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2007, 65 (07) : 1328 - 1331
  • [32] Cytokine Alteration In Multiple Myeloma (MM) Patients and Bisphosphonate (BP)-Related Osteonecrosis Of The Jaw (BRONJ)
    Badros, Ashraf
    Philip, Sunita
    Lesho, Patricia
    Sadowska, Mariola
    Weikel, Dianna
    Meiller, Timothy
    Lapidus, Rena
    Hester, Lisa
    Milliron, Todd
    Goloubeva, Olga
    BLOOD, 2013, 122 (21)
  • [33] Clarithromycin as the empiric antibiotic therapy for medication-related osteonecrosis of the jaw in multiple myeloma patients
    Zadik, Yehuda
    ORAL ONCOLOGY, 2018, 84 : 104 - 105
  • [34] Clinical, radiographic, and biomarker characterization of multiple myeloma patients with bisphosphonate associated osteonecrosis of the jaw.
    Raje, Noopur
    Woo, Sook-Bin
    Hande, Karen
    Yap, Jeffrey T.
    Richardson, Paul G.
    Vallet, Sonia
    Treister, Nathaniel
    Hideshima, Teru
    Tai, Yu-Tzu
    Chhetri, Shweta
    Connell, Brendan
    Szot-Barnes, Agnieszka
    Tian, Mei
    Schlossman, Robert L.
    Weeler, Edie
    Munshi, Nikhil C.
    Van Den Abbeele, Annick D.
    Anderson, Kenneth C.
    BLOOD, 2006, 108 (11) : 1025A - 1026A
  • [35] Concomitant Factors Leading to an Atypical Osteonecrosis of the Jaw in a Patient with Multiple Myeloma
    Miranda-Rius, Jaume
    Brunet-Llobet, Lluis
    Lahor-Soler, Eduard
    Anton Gimenez-Rubio, Josep
    CASE REPORTS IN MEDICINE, 2014, 2014
  • [36] Novel risk factors for osteonecrosis of the jaw in multiple myeloma: A RADAR report
    Holbrook, Jaimee S.
    Trifilio, Steven M.
    Mckoy, June M.
    Singhal, Seema
    Rademaker, Alfred
    Mehta, Jayesh
    Belknap, Steven M.
    Tica, Stefani
    Clark, Sarah Victoria
    Godinez-Puig, Victoria
    Nardone, Beatrice
    Gradishar, William John
    West, Dennis P.
    Edwards, Beatrice J.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [37] Osteonecrosis of the jaw in myeloma patients receiving pamidronate or zoledronate.
    Kut, V
    Mehta, J
    Tariman, J
    Olsson, A
    Singhal, S
    BLOOD, 2004, 104 (11) : 315B - 315B
  • [38] Evolution of Bisphosphonates Related Osteonecrosis of the Jaw (BRONJ) in Patients with Multiple Myeloma (MM): A Retrospective Study.
    Andriani, Alessandro A. A. Alessandro
    Petrucci, Maria Teresa M. T. P.
    Caravita, Tommaso
    Montanaro, Marco
    Pisani, Francesco
    Coppetelli, Ugo
    De Muro, Marianna
    Bongarzoni, Velia
    Avvisati, Giuseppe
    Villiva, Nicoletta
    Levi, Anna
    Siniscalchi, A.
    Agrillo, Alessandro
    Gaglioti, Domenico
    BLOOD, 2008, 112 (11) : 935 - 935
  • [39] Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: Definition and management of the risk related to zoledronic acid
    Cafro, Anna Maria
    CLINICAL LYMPHOMA & MYELOMA, 2008, 8 (02): : 111 - 116
  • [40] Osteonecrosis of the Jaw in Multiple Myeloma Patients: Risk Factors of Early ONJ, Decreased Impact After 2005
    Fuzibet, J. G.
    Rossignol, B.
    Vieillard, M. H.
    Fontas, E.
    Hulin, C.
    Vekemans, M. C.
    Garderet, L.
    Marevoet, M.
    Blanc, M.
    Azais, I.
    Marit, G.
    Facon, T.
    Moreau, P.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S19 - S20
12345